<DOC>
	<DOCNO>NCT01378884</DOCNO>
	<brief_summary>The purpose study determine whether domperidone use safely effectively patient gastroparesis .</brief_summary>
	<brief_title>The Use Domperidone Gastroparesis</brief_title>
	<detailed_description>Individuals diagnose gastroparesis fail least one standard therapy offer trial domperidone possible remedy condition . Patients medication expect follow physician 3 month , 6 month 12months , annually medication . Any change significant adverse reaction medication condition report immediately physician .</detailed_description>
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Domperidone</mesh_term>
	<criteria>1 . Male female 2 . Age 18 old 3 . Symptoms manifestation secondary GERD ( e.g. , persistent esophagitis , heartburn , upper airway sign symptom respiratory symptom ) , gastrointestinal motility disorder nausea , vomit , severe dyspepsia severe chronic constipation refractory standard therapy . 4 . Subjects must comprehensive evaluation eliminate cause symptom . 5 . Subject sign informed consent administration domperidone . The informed consent informs subject potential adverse event include : increase prolactin level , extrapyramidal side effect , breast change , cardiac arrhythmia include QT prolongation , 1 . History current cardiac disease , include ischemic valvular heart disease , structural heart defect , cardiomyopathy congestive heart failure . 2 . History current arrhythmia include ventricular tachycardia , ventricular fibrillation Torsade des Pointes . Subjects minor form ectopy ( PACs ) necessarily exclude . 3 . Clinically significant bradycardia , sinus node dysfunction , heart block . Prolonged QT syndrome ( QTc great 450 millisecond male , great 470 millisecond female ) family history prolong QT syndrome . 4 . Presence prolactinoma ( prolactinreleasing pituitary tumor ) . 5 . Conditions result electrolyte disorder , severe dehydration , vomit , malnutrition , eat disorder , renal disease , use potassiumwasting diuretic insulin acute setting . ( Note presence vomiting , may accompany gastroparesis pseudoobstruction exclude subject accompany electrolyte disturbance must subject exclude . ) 6 . Pregnant breast feed female . 7 . Known allergy domperidone component domperidone formulation . 8 . Significantly significant electrolyte disorder . 9 . Gastrointestinal hemorrhage obstruction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Gastroparesis</keyword>
	<keyword>Domperidone</keyword>
	<keyword>Motilium</keyword>
</DOC>